Rockwell Medical Inc (RMTI) Stock Analysis

Rockwell Medical Inc (RMTI) is a publicly traded company in the HEALTHCARE sector. It trades at $0.71, carries a market capitalization of $28.35M. This page summarizes the public market data, fundamentals, and frequently asked questions for RMTI, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

Market Sentiment

Rockwell Medical Inc currently has a Bullish sentiment score of 0.40.

About Rockwell Medical Inc

Rockwell Medical, Inc. is an innovative biopharmaceutical company focused on addressing the critical needs of patients with end-stage renal disease and chronic kidney disease through its proprietary iron deficiency treatments and hemodialysis solutions. Based in Wixom, Michigan, Rockwell is committed to advancing healthcare for renal patients, with a growing portfolio of products aimed at enhancing patient outcomes both domestically and internationally. The company's strategic focus on renal ...

GNG Research Analysis

GNG Research scores Rockwell Medical Inc (RMTI) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for RMTI.

Frequently Asked Questions

Does RMTI pay dividends?

Rockwell Medical Inc (RMTI) does not currently pay a regular dividend.

What is RMTI's market cap?

Rockwell Medical Inc (RMTI) has a market capitalization of $28.35M with a current stock price of $0.71.